Tag archive for Cancer

Dentist, surgeon begins new era in treating head and neck cancers

Dr. David Kang, assistant professor in oral and maxillofacial surgery, joined Texas A&M University Baylor College of Dentistry as its first head and neck oncologic and microvascular reconstructive surgeon.

Continue Reading→
Male researcher in lab

A collaborative approach to cancer research leads to more than $6 million in CPRIT funding for TAMHSC

The power of team science has landed Texas A&M Health Science Center more than $6.3 million in research funding to further study cancer treatment therapies. It comes at a crucial time in the U.S., as there are an estimated 1.6 million new cancer cases that will be diagnosed in 2015 alone, with nearly 600,000 cancer deaths.

Continue Reading→
Deep sea divers

Renaissance of natural products-based drug research gains momentum with international partnerships and a focus on anti-infective agents

While natural products form the basis of more than half of the therapeutic drugs on the market today, this research arena is experiencing a modern-day renaissance, thanks to advances in synthetic and analytic chemistry, as well as to the major advances in molecular biology and genomics.

Continue Reading→
Dr. Cheryl Walker

Head of Texas A&M IBT Earns Coveted Award from Sigma Xi

Cheryl Lyn Walker, Ph.D., Welch Chair of Chemistry and director of the Texas A&M Institute of Biosciences and Technology, was recently named Outstanding Distinguished Scientist for 2015 by the Texas A&M University Chapter of Sigma Xi. The coveted award is bestowed upon one scientist each year who exhibits exemplary accomplishments in science and engineering.

Continue Reading→
People forming cancer ribbon

Study finds Texas Cancer Plan serves as a good model for other states

A study led by the Texas A&M Health Science Center School of Public Health has the potential to significantly improve the ways that state cancer control programs are developed and implemented around the country.

Continue Reading→
African American patient getting a vaccine from a health care professional

The HPV vaccine: Busting 5 of the most common myths

More than 4,000 women lose their lives to cervical cancer each year. The leading cause of cervical cancer is human papillomavirus , which is also the most common sexually transmitted infection . While HPV vaccines that were approved by the Food and Drug Administration almost a decade ago are proven to reduce incidences of cervical cancer in women, as well as other forms of cancer in both men and women, many parents are still opting not to vaccinate their children.

Continue Reading→
Chemical found in broccoli may offer a new option for treating advanced prostate cancer

Chemical found in broccoli may offer a new option for treating advanced prostate cancer

Broccoli is frequently touted as a food that can help prevent cancer, but could it also be used to treat it? According to research conducted by a faculty member at the Texas A&M Health Science Center Institute of Biosciences and Technology (IBT) in Houston, the answer is yes.

Continue Reading→
Cheryl Walker and team of researchers

Texas A&M researchers awarded CPRIT grant, move breakthroughs from lab into new treatments for endometrial and kidney cancer

The Texas A&M Health Science Center Institute of Biosciences and Technology (IBT) in Houston recently received an early translational research grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to move recent scientific breakthroughs from the laboratory into drug development for cancers with some of the greatest unmet medical need.

Continue Reading→
Dr. Peter Davies sitting at robotic workstation of the high-throughput equipment

Innovative Collaboration: Bringing together people, technology to cure human illness

The Texas A&M Health Science Center brings together scientists across Texas in a multi-institutional academic drug discovery program. With the help of state-of-the-art equipment, the consortium aims to repurpose drugs to treat devastating illnesses, a process that costs a fraction of the time and money it takes to develop an entirely new drug.

Continue Reading→

Additional archives